Archives of Neurology · 1984 · 79 citations · 10 references
PharmacyPharmacokineticsPharmacologyEpilepsyPharmacokinetic VariabilityPharmacovigilanceInterindividual VariabilityTime-dependent Pharmacokinetics12-Hour TimeAntiepileptic Drug SafetyCarbamazepine PharmacologyConcomitant Medication EffectsIntrapatient Variability AnalysisPhenobarbital TherapyPhenobarbital UsePhenytoin Therapy
Fluctuations in plasma carbamazepine concentrations were related to side effects in five epileptics. One patient was receiving only carbamazepine; four were receiving carbamazepine plus phenobarbital sodium or phenytoin sodium. The patients were studied during two 12-hour periods: carbamazepine given (1) twice daily or (2) four times daily. Concomitant medication regimens were kept constant; administration was single-blind. Plasma concentrations of carbamazepine, carbamazepine's epoxide metabolite, phenobarbital, and phenytoin were determined hourly; side effects were assessed simultaneously. Fluctuations in carbamazepine concentrations were 79% +/- 29% higher than trough levels on a twice-daily dosage schedule and 40% +/- 13% higher during four-times-a-day administration. The appearance and intensity of side effects followed the fluctuations in carbamazepine levels and were thus substantially reduced during the four-times-daily regimen. The intrapatient reproducibility of the side effects was good, whereas the thresholds of carbamazepine concentrations at which side effects appeared ranged from 17 to 37 mumole/L.
10
Correlation Between Daily Fluctuations of Carbamazepine Serum Levels and Intermittent Side Effects
R. J. Höpener, A. Kuyer, J. W. A. Meijer et al. · Epilepsia · 1980 · 108 citations
Carbamazepine—A double‐blind comparison with phenytoin
Allan S. Troupin, LINDA MORETTl OJEMANN, Lawrence A. Halpern et al. · Neurology · 1977 · 90 citations
Carbamazepine Therapy in Trigeminal Neuralgia
Torbjörn Tomson · Archives of Neurology · 1980 · 73 citations